Virtual Event | September 13, 2022

CMC Changes & Regulatory Interaction

Source: Cytiva

What specific biopharma CMC changes invite regulatory scrutiny? Pretty much all of them. In this segment of the Bioprocess Online Live event Regulatory Harmonization Meets CMC Realities, Steffi Pluschkell, Ph.D., former Pfizer Head of Business Strategy and Operations and current CEO of InScope Coaching & Consulting, Bioprocess Online Chief Editor Matt Pillar, and Alira Health Senior VP of CMC Steven Chamow, Ph.D. discuss the most common—and where many biopharma leaders get tripped up.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva